BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
Using almost $30 million in funding, an all-in-one vaccine is being developed to bring new protection against a range of new and existing coronavirus variants.
In a huge blow to Boris Johnson’s government, ministers, parliamentary private secretaries, and more have begun a mass cabinet resignation. What’s next?
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
Dr Hans Henri P. Kluge & Dr Natasha Azzopardi Muscat explain the importance of putting health at the heart of tourism, including a commitment made in this vein by Europe’s smallest countries to better health systems.
Spiralling inflation, rising energy bills and an escalating cost of living crisis have left millions of people struggling to afford basic necessities; could future predictive modelling stop this from happening again.
Kayoko ITO, a professor at Osaka Prefecture University, looks at child abuse among families during COVID-19 and the measures taken to combat it through child and family counselling.
